Digital Breast Tomosynthesis denials in California external review

In the California DMHC record, independent physician reviewers decided 381 published external-review cases involving Digital Breast Tomosynthesisand overturned the plan’s denial in 95%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
381
2013–2021
Overturned
95%
362 denials reversed

By condition

Published outcomes when Digital Breast Tomosynthesis was denied for these conditions.
ConditionDecisionsOverturned
Dense Breast Tissue81
100%
Breast Cancer Screening34
97.1%
Heterogeneously Dense Breast Tissue21
100%
Breast Cancer14
100%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
378
95.2%
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
3
66.7%
Typical time to a decision
15 days
Most land between 12 and 20 days
Recent direction
Rising
90.6%95.4% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for digital breast tomosynthesis that were performed for the evaluation of the enrollee, who presented for breast examination. Findings: Two physician reviewers found that the patient was asymptomatic with respect to her breasts. She had a prior left breast biopsy. She underwent a routine screening mammogram consisting of a three dimensional tomosynthesis study with synthetically reconstructed two dimensional views. Those images were compared to prior. In one image there was an area of asymmetry noted in the left breast. In addition, there was a nodular area noted in the retroareolar area of the right breast. Following that screening study, it was recommended that the patient return for additional imaging. The patient’s breasts were described as heterogeneously dense.
Experimental/Investigational · 2017 · IMR EI17-24425
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for digital breast tomosynthesis that was performed for evaluation of the enrollee, who presented for a breast screening mammogram. Findings: 2/3 of the physician reviewers found that the patient is a female who was asymptomatic with respect to her breasts. She underwent a routine screening mammogram consisting of two dimensional conventional views. That study was compared to prior mammograms, and it was noted that there was a new nodule in the axillary tail of her left breast, and additional imaging was recommended. At that time, her breasts were described as having scattered fibroglandular densities. Subsequently, she returned for a diagnostic left sided study and she had a combination two dimensional and three dimensional tomosynthesis study of her left breast.
Experimental/Investigational · 2016 · IMR EI16-24224

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for the digital breast tomosynthesis for evaluation of the enrollee’s risk for breast cancer. Findings: 2/3 of the physician reviewers found that Tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography (CT) scanning, by separating the various layers of breast tissue, one can better detect abnormalities. However, in this particular patient, there were no problems to be resolved. That is, the patient did not have dense breasts, she did not have a mass, there were no palpable lumps, and she did not have suspicious calcifications.
Experimental/Investigational · 2016 · IMR EI16-23818
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for the digital breast tomosynthesis performed for evaluation of the enrollee’s risk for breast cancer. Findings: 2/3 of the physician reviewers found that Tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography (CT) scanning, by separating the various layers of breast tissue, one can better detect abnormalities. However, in this particular patient, there were no problems to be resolved since the patient does not have dense breasts, she did not have a mass, there were no palpable lumps, and she did not have suspicious calcifications. The 2D images were reconstructed from the primary tomosynthesis acquisition, thus a routine mammogram would have been sufficient.
Experimental/Investigational · 2016 · IMR EI16-24175

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Digital Breast Tomosynthesis, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Digital Breast Tomosynthesis? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39